Long-term use of inhaled corticosteroids reduces the incidence of pleural effusion in patients with community acquired pneumonia

Dr. Jacob Sellarés

Prior treatment with inhaled corticosteroids in patients with respiratory disorders who develop community acquired pneumonia (CAP) is associated with a lower incidence and severity of parapneumonic effusion. That is the conclusion of a research funded by CIBERes and IDIBAPS led by Dr. Jacob Sellarés, MD, PhD, associate faculty member at the Hospital Clínic - IDIBAPS de Barcelona. The results were presented at the American Thoracic 2012 International Conference held in San Francisco on May, and were recently commented by the newspaper Diario Médico.

Information via: www.idibapsrespiratoryresearch.org